The JDF Center for Islet
Cell Transplantation will fund 32 researchers to focus on four main goals: Reversing the overactive immune response that kills islet cells; finding new sources for islet cell transplants, such as pigs or genetically engineered cells; persuading the body to accept the transplanted cells without immunosuppressive drugs that often trigger worse side effects than the disease; and overcoming the technical difficulties of transplantat
Cell Transplantation will fund 32 researchers to focus on four main goals: Reversing the overactive immune response that kills islet cells; finding new sources for islet cell transplants, such as pigs or genetically engineered cells; persuading the body to accept the transplanted cells without immunosuppressive drugs that often trigger worse side effects than the disease; and overcoming the technical difficulties of t
Transplantation will fund 32 researchers to focus on four main goals: Reversing the overactive immune response that kills islet
cells; finding new sources for islet
cell transplants, such as pigs or genetically engineered cells; persuading the body to accept the transplanted cells without immunosuppressive drugs that often trigger worse side effects than the disease; and overcoming the technical difficulties of transplantat
cell transplants, such as pigs or genetically engineered
cells; persuading the body to accept the transplanted
cells without immunosuppressive drugs that often trigger worse side effects than the disease; and overcoming the technical difficulties of
transplantationtransplantation.
Trapnell and Suzuki were prompted to test the novel macrophage
transplantation therapy by studies showing that resident macrophage populations (such as those residing in the lung) can self - maintain
without the
cells having to regenerate directly from the bone marrow.